Fuse Medical, Inc. FZMD
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 296.33% | 286.12% | 273.21% | -11.48% | -- |
| Total Depreciation and Amortization | -42.90% | -28.25% | -8.12% | 156.95% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -313.15% | -320.51% | -347.43% | -141.84% | -- |
| Change in Net Operating Assets | -389.47% | -205.95% | -283.96% | -267.19% | -- |
| Cash from Operations | 76.21% | 58.84% | 78.17% | -30,815.69% | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 200.02% | 200.07% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | 595.09% | -- |
| Total Debt Repaid | 79.76% | 91.37% | 73.05% | -1,487.65% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -139.00% | -141.24% | -138.48% | 83.01% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 53.43% | 65.21% | 36.10% | -656.23% | -- |